Lisinopril is indicated for:
Acute myocardial infarction
Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction.
Renal complications of diabetes mellitus
Treatment of renal disease in hypertensive patients with Type 2 diabetes mellitus and incipient nephropathy (see section 5.1 of the EMC).
Summary of Product Characteristics
Read this summary of product characteristics for further information about Lisinopril Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Lisinopril Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Lisinopril Oral Solution
|Click here for Audio Version
|Shelf Life (Closed Bottle/Open Bottle)
|3 years/30 days
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.